Abstract:In addition to soluble factors and stromal cells, the mechanical properties of extracellular matrix (ECM) are considered to be an important component of tumor microenvironment. In particular, substrate stiffness is a mechanical characteristic of the ECM by which certain anchorage cells sense and respond to a variety of cellular behaviors. At the same time, clinical studies have observed that substrate stiffness was increased during tumorigenesis, which could promote tumor malignant transformation and metastasis. However, the biomechanical behavior of tumor cells and the underlying mechanotransduction pathways remain unclear. Here, using stiffness‐regulable polyacrylamide (PAA) substrates to simulate the tissue stiffness at different progress stages of breast cancer in vitro, we found that moderate substrate stiffness induced the emergence of malignant phenotypes and further unregulated breast cancer cell motility. Subcellular structure observation showed that moderate substrate stiffness promote the formation of leading‐edge protrusion by accelerating focal adhesion maturation and polarizing intracellular traction force distribution. Moreover, the substrate stiffness directly activated integrin β1 and focal adhesion kinase (FAK), which accelerate focal adhesion (FA) maturation and induce the downstream cascades of intracellular signals of the RhoA/ROCK pathway. Interestingly, the differential regulatory mechanism between two ROCK isoforms (ROCK1 and ROCK2) in cell motility and mechanotransduction was clearly identified. ROCK1 phosphorylated the myosin‐regulatory light chain (MRLC) and facilitated the generation of traction force, while ROCK2 phosphorylated cofilin and regulated the cytoskeletal remodeling by suppressing F‐actin depolymerization. The ROCK isoforms differentially regulated the pathways of RhoA/ROCK1/p‐MLC and RhoA/ROCK2/p‐cofilin in a coordinate fashion to modulate breast cancer cell motility in a substrate stiffness‐dependent manner via integrin β1‐activated FAK signaling. Our findings provide new insights into the mechanisms of matrix mechanical property‐induced cancer cell migration and malignant behaviors. Taming these physical forces by implanting scaffolds with specific stiffness or by inhibiting specific ROCK isoforms could have potential implications for improving therapeutic outcomes in cancer.Support or Funding InformationThis work was supported, in part or in whole, by the National Natural Science Foundation of China (11772088, 31470906, 31700811, 11802056, and 31800780).This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Mechanotransduction in Response to ECM Stiffening Impairs Cgas Immune Signaling in Tumor Cells.

Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy

Insights into the mechanisms, regulation, and therapeutic implications of extracellular matrix stiffness in cancer

Targeting extracellular matrix stiffness for cancer therapy

Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy

3D Microenvironment Stiffness Regulates Tumor Spheroid Growth and Mechanics via p21 and ROCK

Stiffer Matrix Accelerates Migration of Hepatocellular Carcinoma Cells Through Enhanced Aerobic Glycolysis Via the MAPK-YAP Signaling

Unveiling the Mechanotransduction Mechanism of Substrate Stiffness‐modulated Cancer Cell Motility Via ROCK1 and ROCK2 Differentially Regulated Manner

Mechano-mediated M2 macrophage polarization and immune suppression in stiffened tumor microenvironment

The Role of Matrix Stiffness in Cancer Stromal Cell Fate and Targeting Therapeutic Strategies

Mtorc1 Mediates Biphasic Mechano‐Response to Orchestrate Adhesion‐Dependent Cell Growth and Anoikis Resistance

Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment

Enhancement effects of extracellular fluid viscosity and matrix stiffness on cancer cell mechanosensing

T cell polarization and NFAT translocation are stiffness-dependent and are differentially regulated by Piezo1 and Orai1

ROCK isoforms differentially modulate cancer cell motility by mechanosensing the substrate stiffness

The key role of matrix stiffness in colorectal cancer immunotherapy: mechanisms and therapeutic strategies

Increased matrix stiffness in pituitary neuroendocrine tumors invading the cavernous sinus is activated by TAFs: focus on the mechanical signatures

Mechanosensitive turnover of phosphoribosyl pyrophosphate synthetases regulates nucleotide metabolism

Increased matrix stiffness in pituitary neuroendocrine tumors invading the cavernous sinus is activated by CAFs through the mTOR pathway

Tumor Microenvironment‐Activatable Nanoenzymes for Mechanical Remodeling of Extracellular Matrix and Enhanced Tumor Chemotherapy

Matrix Stiffness-Driven Cancer Progression and the Targeted Therapeutic Strategy